Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2009
03/12/2009US20090069387 Animal parasite-control method using insect growth regulators
03/12/2009US20090069386 Liquid Composition, Process for Producing the Liquid Composition,and Ectoparasite Controlling Agent for Use in Mammals and Avians
03/12/2009US20090069385 Antidiabetic Oxazolidinediones and Thiazolidinediones
03/12/2009US20090069384 Thienopyrroles useful in the treatment of inflammation
03/12/2009US20090069383 Thrombin Receptor Antagonists
03/12/2009US20090069382 Bicyclic Angiotensin II Agonists
03/12/2009US20090069381 Deuterium-enriched raloxifene
03/12/2009US20090069380 Deuterium-enriched aroxifene
03/12/2009US20090069379 Deuterium-enriched lenalidomide
03/12/2009US20090069378 Deuterium-enriched donepezil
03/12/2009US20090069377 Deuterium-enriched enzastaurin
03/12/2009US20090069376 Substituted N [N-(sulphonylphenyl)sulfonyl-prolyl]-phenylalanine derivatives are antagonists of the very late antigen-4 integrin; ulcerative colitis, Crohn's disease, asthma, multiple sclerosis, rheumatoid arthritis
03/12/2009US20090069375 Deuterium-enriched miglustat
03/12/2009US20090069374 Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]Hexanes, Methods For Their Preparation And Their Use As Medicaments
03/12/2009US20090069373 Quinoline Acids
03/12/2009US20090069372 Antitumor agents
03/12/2009US20090069371 Isoquinoline compounds
03/12/2009US20090069370 Azacyclylisoquinolinone and isoindolinone derivatives as histamine-3 antagonists
03/12/2009US20090069369 Deuterium-enriched prasugrel
03/12/2009US20090069368 Fgf-receptor agonist dimeric compounds
03/12/2009US20090069367 Methods for treatment of cancer
03/12/2009US20090069366 Deuterium-enriched tacrolimus
03/12/2009US20090069365 Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators
03/12/2009US20090069364 Pharmaceutical compositions of 5-alpha-reductase inhibitors and methods of use thereof
03/12/2009US20090069363 Therapeutic Agent for Constipation
03/12/2009US20090069362 Novel Spiro-benzo[c]chromene derivatives useful as modulators of the estrogen receptors
03/12/2009US20090069361 Methods of treatment using (+)- isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1, 4-dihydro-2, 6-dimethyl-pyridine-3, 5-dicarboxylate
03/12/2009US20090069360 Organic Compounds
03/12/2009US20090069359 A formulation for treatment of alopecia contains minoxidil, urea, hydrocortisone and a skin desquamation agent comprising tretinoin
03/12/2009US20090069358 Use of IKappaB-Kinase Inhibitors in Pain Therapy
03/12/2009US20090069357 Deuterium-enriched iclaprim
03/12/2009US20090069355 Bicyclic pyrazolone cytokine inhibitors
03/12/2009US20090069354 Deuterium-enriched gemcitabine
03/12/2009US20090069353 Deuterium-enriched ambrisentan
03/12/2009US20090069352 Deuterium-enriched clazosentan
03/12/2009US20090069351 Deuterium-enriched bosentan
03/12/2009US20090069350 Pharmaceutical compositions and use thereof
03/12/2009US20090069349 Deuterium-enriched pemetrexed
03/12/2009US20090069348 Use of Inhibitors of the Renin-Angiotensin System
03/12/2009US20090069347 2-phenoxy pyrimidinone analogues
03/12/2009US20090069345 Pharmaceutically Stable Compound Consisting of Timolol, Dorzolamide and Brimonidine
03/12/2009US20090069344 Modulators of hcv replication
03/12/2009US20090069343 Combination Histamine H1R and H4R Antagonist Therapy for Treating Pruritus
03/12/2009US20090069342 1-N-amino-2-imidazolidinones and derivatives thereof which are effective as Kv1.5 potassium channel inhibitors providing atrial-selective antiarrhythmic agents; 1-(aminosulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(3,4-dimethylphenyl)-2-imidazolidinone
03/12/2009US20090069341 Inhibitors of hsp90
03/12/2009US20090069340 Pyrazolone Compounds As Metabotropic Glutamate Receptor Agonists For The Treatment Of Neurological And Psychiatric Disorders
03/12/2009US20090069339 Deuterium-enriched ciprofloxacin
03/12/2009US20090069338 Method for predicting skin sensitizing activity of compounds
03/12/2009US20090069337 3' substituted compounds having 5-ht6 receptor affinity
03/12/2009US20090069336 Pyrimidothiophene compounds
03/12/2009US20090069335 Guanidine-containing compounds useful as muscarinic receptor antagonists
03/12/2009US20090069334 Pyridazine based alpha-helix mimetics
03/12/2009US20090069332 Novel pyridazine derivatives and medicines containing the same as effective ingredients
03/12/2009US20090069331 Guanidine derivatives as inhibitors of ddah
03/12/2009US20090069330 Substituted Oxazole Compounds with Analgesic Activity
03/12/2009US20090069329 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
03/12/2009US20090069328 Alpha-alkyl substituted n-acyltryptophanols
03/12/2009US20090069327 Compounds and compositions as protein kinase inhibitors
03/12/2009US20090069326 (R)-3-{3,5-Dichloro-4'-[4-(2-fluoro-ethyl)-piperazine-1-carbonyl]-biphenyl-4-ylmethyl}-1-(4,4-difluoro-cyclohexyl)-pyrrolidin-2-one, used for the treatment of diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome and cognitive disorders
03/12/2009US20090069325 Piperidine Derivatives Useful as Modulators of Chemokine Receptor Activity
03/12/2009US20090069324 Chemical inhibitors of bfl-1 and related methods
03/12/2009US20090069323 11beta-hsdi inhibitors
03/12/2009US20090069322 N-formyl hydroxylamine derivatives as inhibitors of bacterial polypeptide formylase for treating microbial infections
03/12/2009US20090069321 Cyanomethyl substituted n-acyl tryptamines
03/12/2009US20090069320 Substituted 4-Amino-Quinazoline Compounds with Metabotropic Glutamate Receptor Regulating Activity and Uses Thereof
03/12/2009US20090069319 Imidazopyridine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
03/12/2009US20090069318 Novel Compounds
03/12/2009US20090069316 Novel quinoline derivatives
03/12/2009US20090069315 Use of Pyrazolo(1,5A)Pyrimidin-7-YL Amine Derivatives in the Treatment of Neurological Disorders
03/12/2009US20090069314 Hydroxyalkyl Substituted Imidazoquinoline Compounds and Methods
03/12/2009US20090069313 Novel MAO-A inhibitors
03/12/2009US20090069312 Potassium Channel Inhibitors
03/12/2009US20090069311 histamine H3-antagonists such as [5-(1-ethyl-piperidin-4-ylamino)-1H-indol-2-yl]-piperidin-1-yl-methanone, used for the treatment of obesity or eating disorders, and non-insulin dependent diabetes
03/12/2009US20090069310 Anti-inflammatory medicaments
03/12/2009US20090069309 Prostaglandin analogs
03/12/2009US20090069308 Novel Use of Antihistamine Agents for the Preventive or Early Treatment of Inflammatory Syndromes, in Particular Those Triggered by Togaviruses
03/12/2009US20090069307 Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions
03/12/2009US20090069306 Process for producing highly pure midazolam and salts thereof
03/12/2009US20090069305 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor
03/12/2009US20090069304 Mmp-13 selective inhibitor
03/12/2009US20090069303 Phthalazinone derivatives
03/12/2009US20090069302 Chemical compounds
03/12/2009US20090069301 Acridine and Quinoline Derivatives as Sirtuin Modulators
03/12/2009US20090069300 Isoquinolinyl and isoindolinyl derivatives as histamine-3 antagonists
03/12/2009US20090069299 Pyrazolo[3,4-c]Quinolines, Pyrazolo[3,4-c]Naphthyridines, Analogs Thereof, and Methods
03/12/2009US20090069298 Pyrazolo[1,5-A]Pyrimidine Compounds
03/12/2009US20090069297 protein kinase inhibnitors such as N-(4-((7-(methyloxy)-1,5-naphthyridin-4-yl)oxy)phenyl)-4-phenyl-1-phthalazinamine, for influencing the process of cell cycle and cell proliferation to treat cancer; anticarcinogenic agents
03/12/2009US20090069296 1,2,4,5-Tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them
03/12/2009US20090069295 Deuterium-enriched conivaptan
03/12/2009US20090069294 Organic Compounds
03/12/2009US20090069293 Succinoylamino benzodiazepines as inhibitors of ab protein production
03/12/2009US20090069292 Liquid Formulations
03/12/2009US20090069291 Salt Forms
03/12/2009US20090069290 Administering formulation selected from calcium-channel blocker; a combination of a calcium-channel blocker and glutamate inhibitor; a combination of a calcium-channel blocker and hypertensive agent or mixtures
03/12/2009US20090069289 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression
03/12/2009US20090069288 Novel therapeutic compounds
03/12/2009US20090069287 Substituted azacycloalkanes useful for treating cns conditions
03/12/2009US20090069286 Deuterium-enriched aztreonam
03/12/2009US20090069285 Diphenylazetidinone Derivatives Possessing Cholesterol Absorption Inhibitor Activity
03/12/2009US20090069284 Substituted 3-alkyl and 3-alkenyl azetidine derivatives
1 ... 2829 2830 2831 2832 2833 2834 2835 2836 2837 2838 2839 2840 2841 2842 2843 2844 2845 2846 2847 2848 2849 ... 7860